UC BON.CAP.CERT. 06/25 PFE/ DE000HD3TXP1 /
29/05/2024 21:45:00 | Var.-0.750 | Denaro21:59:59 | Lettera21:59:59 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
32.930EUR | -2.23% | 32.810 Quantità in denaro: 4,000 |
32.820 Quantità in lettera: 4,000 |
Pfizer Inc | - USD | 27/06/2025 | Call |
GlobeNewswire
23:03
Kessler Topaz Meltzer & Check, LLP Reminds Inari Medical, Inc. Investors of Important Deadline in Se...
GlobeNewswire
23:01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agrify Corp...
Newsfile Corp
23:01
IAMGOLD annonce les résultats de l'assemblée générale et extraordinaire annuelle des actionnaires
GlobeNewswire
23:00
Lilium Announces Successful Arrangement of $114 Million Capital Raise With Participation From Strate...
GlobeNewswire
22:56
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, I...
GlobeNewswire
22:46
Biogen Inc. (Nasdaq: BIIB) Investors Notice: Class action lawsuit filed on behalf of investors; the ...
GlobeNewswire
22:45
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:43
Li Auto Inc. (LI) Investors: July 9, 2024 Filing Deadline in Securities Class Action - Contact Kessl...
GlobeNewswire
22:30
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
GlobeNewswire
22:30
X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinica...